Mark A. Hull
Impact in
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
Papers in ⓘ
- Oncology 36
- Colorectal Cancer Screening and Detection 22
- Pharmacology 35
- Inflammatory mediators and NSAID effects 35
- Co-authors
- Gillian Hawcroft (14 shared papers)Paul M. Loadman (19 shared papers)P. Louise Coletta (16 shared papers)Melvyn Smith (1 shared paper)Giles J. Toogood (11 shared papers)Prashant Kant (5 shared papers)Venkataraman Subramanian (7 shared papers)Nicholas Burr (5 shared papers)
- Journals
- Gut (9 papers)Gastroenterology (5 papers)International Journal of Cancer (3 papers)Nature Reviews Gastroenterology & Hepatology (3 papers)European Journal of Cancer (3 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Mark A. Hull
106 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Pharmacology 1.1k
- Cancer Research 829
- Oncology 1.2k
- Biochemistry 301
- Nutrition and Dietetics 479
Countries citing papers authored by Mark A. Hull
This map shows the geographic impact of Mark A. Hull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Hull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Hull more than expected).
Fields of papers citing papers by Mark A. Hull
This network shows the impact of papers produced by Mark A. Hull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Hull. The network helps show where Mark A. Hull may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Hull, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota Hit paper breakdown → | 2017 | 379 |
| 2 | 2000 | 230 | |
| 3 | 2011 | 199 | |
| 4 | 2000 | 187 | |
| 5 | 2010 | 170 | |
| 6 | 2004 | 130 | |
| 7 | 2005 | 124 | |
| 8 | 1999 | 116 | |
| 9 | 2018 | 112 | |
| 10 | 2013 | 104 | |
| 11 | 2013 | 99 | |
| 12 | 2014 | 89 | |
| 13 | 2020 | 88 | |
| 14 | 2011 | 85 | |
| 15 | 2018 | 79 | |
| 16 | 2018 | 77 | |
| 17 | 2012 | 76 | |
| 18 | 2001 | 75 | |
| 19 | 2017 | 75 | |
| 20 | 2003 | 73 |
About Mark A. Hull
Mark A. Hull is a scholar working on Oncology, Pharmacology, Surgery, Cancer Research and Molecular Biology, having authored 111 papers that have together received 4.2k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (35 papers), Cancer, Lipids, and Metabolism (22 papers), Colorectal Cancer Screening and Detection (22 papers), Fatty Acid Research and Health (19 papers), Helicobacter pylori-related gastroenterology studies (16 papers), Gastric Cancer Management and Outcomes (16 papers), Estrogen and related hormone effects (12 papers) and Genetic factors in colorectal cancer (8 papers). The work is most often cited by research in Pharmacology (1.1k citations), Cancer Research (829 citations), Oncology (1.2k citations), Biochemistry (301 citations) and Nutrition and Dietetics (479 citations). Mark A. Hull has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Gillian Hawcroft, Paul M. Loadman, P. Louise Coletta, Melvyn Smith, Giles J. Toogood, Prashant Kant, Venkataraman Subramanian, Nicholas Burr, Milène Volpato and Andrea Belluzzi. Their work appears in journals such as Gut, Gastroenterology, International Journal of Cancer, Nature Reviews Gastroenterology & Hepatology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.